Kedoya Adyaraya Past Earnings Performance
Past criteria checks 4/6
Kedoya Adyaraya's earnings have been declining at an average annual rate of -1.2%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 4.9% per year. Kedoya Adyaraya's return on equity is 5.2%, and it has net margins of 9.3%.
Key information
-1.2%
Earnings growth rate
-33.8%
EPS growth rate
| Healthcare Industry Growth | 14.1% |
| Revenue growth rate | 4.9% |
| Return on equity | 5.2% |
| Net Margin | 9.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Kedoya Adyaraya makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 433,853 | 40,390 | 111,925 | 0 |
| 30 Jun 24 | 419,127 | 36,253 | 96,582 | 0 |
| 31 Mar 24 | 399,434 | 32,742 | 90,228 | 0 |
| 31 Dec 23 | 373,400 | 25,189 | 93,782 | 0 |
| 30 Sep 23 | 368,022 | 24,256 | 76,243 | 0 |
| 30 Jun 23 | 372,247 | 31,793 | 72,801 | 0 |
| 31 Mar 23 | 360,480 | 23,394 | 78,658 | 0 |
| 31 Dec 22 | 359,156 | 26,180 | 73,957 | 0 |
| 30 Sep 22 | 354,747 | 3,523 | 84,316 | 0 |
| 30 Jun 22 | 367,030 | 2,580 | 82,130 | 0 |
| 31 Mar 22 | 405,729 | 34,501 | 78,267 | 0 |
| 31 Dec 21 | 435,196 | 52,909 | 74,137 | 0 |
| 30 Sep 21 | 443,145 | 84,039 | 58,465 | 0 |
| 31 Dec 20 | 294,917 | 19,989 | 49,283 | 0 |
| 31 Dec 19 | 284,704 | 22,680 | 69,009 | 0 |
| 31 Dec 18 | 242,988 | 12,723 | 68,719 | 0 |
Quality Earnings: RSGK has high quality earnings.
Growing Profit Margin: RSGK's current net profit margins (9.3%) are higher than last year (6.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RSGK's earnings have declined by 1.2% per year over the past 5 years.
Accelerating Growth: RSGK's earnings growth over the past year (66.5%) exceeds its 5-year average (-1.2% per year).
Earnings vs Industry: RSGK earnings growth over the past year (66.5%) exceeded the Healthcare industry 2.7%.
Return on Equity
High ROE: RSGK's Return on Equity (5.2%) is considered low.